“But, if we do in fact get a favorable response
Post# of 148181
I agree, but I have to say, I still feel as though BTD was filed prematurely. Not in the sense that patients aren’t responding to leronlimab, but that there’s only data from a handful of patients. I personally would’ve liked CYDY to file for BTD around this time, having data from 5 patients over multiple months and data expected from a few more. Of course, I’m no Dr. Patterson or other CYDY medical expert, just a CYDY investor who wanted a little bit thicker BTD packet.